Kiromic Biopharma - Delisted Stock
Kiromic Biopharma is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Kiromic Biopharma was actively traded.
Valuation
Check how we calculate scores
Kiromic Biopharma Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Kiromic Biopharma market risk premium is the additional return an investor will receive from holding Kiromic Biopharma long position in a well-diversified portfolio.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.20) | |||
Total Risk Alpha | (1.22) | |||
Treynor Ratio | (0.47) |
View Kiromic Biopharma Related Equities
Risk & Return | Correlation |
Kiromic Biopharma Corporate Management
Michael Ryan | Chief Officer | Profile | |
Leonardo Mirandola | Chief Officer | Profile | |
JD CPA | CEO Director | Profile | |
Daniel Clark | Chief Officer | Profile | |
MD PharmD | Chief Staff | Profile |
Still Interested in Kiromic Biopharma?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |